EN DE
Watch PT Lupromax Pelumas Indonesia Tb for free: we tell you when fair value or trend changes.
Data-driven stock valuation

PT Lupromax Pelumas Indonesia Tb (LMAX) fair value: what the stock is really worth

As of Nov 10, 2026: fair value (intrinsic value) of PT Lupromax Pelumas Indonesia Tb stock IDR 75, price IDR 75, that is 0.5% below the price, quality 67 out of 100. Rating: fairly valued. Calculated from audited financials with 20 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Energy ID

PL PT Lupromax Pelumas Indonesia Tb logo Thin data Nov 10, 2026

PT Lupromax Pelumas Indonesia Tb

LMAX · JK
Fairly valued, in an uptrend

The stock costs about what our calculation considers fair.

Quality 67/100
Low debt
Fair value 74.62 IDR · Fairly valued
Mixed Growth (revenue YoY +71.8 %/yr in IDR)
Thin margins · 1.1% net margin (TTM)
Revenue last quarter 12% below a year ago.
Trails peers (4/11)
Narrow moat 28/100 · thin data
Thin data
⟳ Cyclical⚠ Small free float
Watch PT Lupromax Pelumas Indonesia Tb for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

362.00 IDR 14.00 IDR Fair Value 74.62 IDR Aug 2023 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

39‑month range 14.00 IDR – 362.00 IDR · fair‑value band 63.96 IDR – 93.22 IDR · the 75.00 IDR price screens above the 74.62 IDR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow PT Lupromax Pelumas Indonesia Tb in your weekly email

Every Wednesday you see whether PT Lupromax Pelumas Indonesia Tb is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

PT Lupromax Pelumas Indonesia Tbk distributes and sells lubricating oil to the retail and automotive sectors in Indonesia. The company offers additive products, including engine additives, fuel additives, and aerosol.

Show moreShow less

It also provides oil products, such as gasoline engine, motorcycle, diesel engine, transmission, and industrial oils. The company was founded in 2017 and is based in Tangerang, Indonesia.

Stock analysis

PT Lupromax Pelumas Indonesia Tb (LMAX) currently trades at 75.00 IDR, while our model-based Fair Value estimate is 74.62 IDR, so the stock looks roughly fairly valued today (gap 0.5%).

Show more

Valuation

Bull case: the Multiples group reads highest at a median of 96.46 IDR per share, and 8 of the 20 models we run sit above the 75.00 IDR price.

Bear case: the Economic Profit group reads lowest at 58.08 IDR, and 12 of the 20 models stay below the price. Data coverage for this calculation is low.

Scenario range: 63.96 IDR (bear) to 93.22 IDR (bull), the price of 75.00 IDR sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 67/100 (solid quality), in the Energy sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

PT Lupromax Pelumas Indonesia Tb reported revenue of 78.3B IDR in FY2024 versus 37.7B IDR in FY2022, a compound +44.1%/yr. Reported net income was 955M IDR in FY2024, compounding −39.2%/yr from FY2022.

Key figures

Market cap 54.6B IDR (≈ $3.0M) Micro · P/S ratio 0.81 · Net margin 1.1% · Return on equity 1.4% · Return on assets (EBIT) 6.9% (3-year average) · Operating margin 3.1% · Revenue (TTM) 67.7B IDR · Revenue growth (YoY) −12.1%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (low confidence).

What moves the price

The share trades about 67% below its 52-week high and 32% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Energy peers we cover trades at −47% fair-value upside, at −1%, LMAX screens cheaper than that median.

Fair Value models

Bear 63.96 IDR Fair Value 74.62 IDR Bull 93.22 IDR
Price 75.00 IDR · Downside -0.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF 63.96 IDR 72.17 IDR 96.32 IDR 73
EPV 67.92 IDR 70.87 IDR 73.28 IDR 71
Growth DCF 62.72 IDR 74.62 IDR 93.22 IDR 71
All 20 models by family
DCF Models
FCF DCF 63.96 IDR 72.17 IDR 96.32 IDR 73
5Y Revenue Exit 76.95 IDR 104.41 IDR 162.18 IDR 64
5Y P/E Exit 63.53 IDR 85.33 IDR 114.74 IDR 63
10Y Revenue Exit 70.99 IDR 109.45 IDR 136.07 IDR 60
10Y P/E Exit 63.67 IDR 84.21 IDR 117.22 IDR 57
Earnings-Based
Graham-Dodd 9.99 IDR 69.69 IDR 97.81 IDR 56
Lynch FV 36.01 IDR 51.44 IDR 66.87 IDR 54
PEG = 1.0 36.01 IDR 51.44 IDR 66.87 IDR 51
EPV 67.92 IDR 70.87 IDR 73.28 IDR 71
Multiples
P/E Multiple 18.74 IDR 24.98 IDR 31.23 IDR 63
P/S Multiple 18.74 IDR 24.98 IDR 31.23 IDR 58
P/B Multiple 174.44 IDR 232.58 IDR 290.73 IDR 55
EV/EBIT 86.46 IDR 100.46 IDR 114.47 IDR 66
EV/Revenue 80.85 IDR 96.46 IDR 112.07 IDR 54
Asset-Based
NCAV (Graham) 47.90 IDR 72.58 IDR 90.72 IDR 54
Growth DCF
Growth DCF 62.72 IDR 74.62 IDR 93.22 IDR 71
Rev-Margin DCF 80.56 IDR 112.95 IDR 180.38 IDR 63
Economic Profit
Residual Income 43.44 IDR 45.29 IDR 49.57 IDR 63
ROIC Compounder 67.92 IDR 70.87 IDR 73.28 IDR 64
Growth Earnings
Growth-Adj P/E 44.30 IDR 63.28 IDR 82.27 IDR 60

Open the full fair value analysis →

Quality Score breakdown

Overall quality 67/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 44
How much profit the company makes from its sales and capital
Quality Growth 62
Are margins and returns getting better?
Cashflow 49
Do the profits arrive as real cash?
Financial strength 82
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 19
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 16
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 77/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 3 usable fiscal years, at least 4 required
not computed

Watch LMAX, get fair value alerts →

Compare PT Lupromax Pelumas Indonesia Tb with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Oil & Gas Refining & Marketing · 119 stocks

Beats the industry median on 4/11 measures
Overall it trails its industry peers.
Valuation
Quality Score 67 · Top 25%
Fair Value upside +0.8% · Above median
Profitability
Return on equity (12 months) 1.4% · Bottom 25%
Return on assets 1.4% · Below median
Net margin (12 months) 1.1% · Below median
Operating margin (12 months) 3.1% · Below median
Growth and dividend
Revenue growth (quarter YoY) −12.1% · Bottom 25%
Balance sheet
Debt / equity 0.03× · Lowest 25%

Valuation Multiplesvs Oil & Gas Refining & Marketing median · lower = cheaper

P/B 1.08× · Cheaper than median
P/S (12 months) 0.81× · Pricier than median
EV/EBITDA 9.9× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)34 · sector 30
FUTURE (revenue growth)0 · sector 100
PAST (return on equity)6 · sector 45
HEALTH (low debt)99 · sector 85
DIVIDEND (yield)0 · sector 65

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Oil & gas

Similar stocks

10 more Oil & Gas Refining & Marketing stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Bharat Petroleum Corporation BPCL ₹316.00 ₹434.58 +38% vs LMAX
SK Innovation Co 096770 106,700 KRW 114,385 KRW +7% vs LMAX
Türkiye Petrol Rafinerileri A.S., TUPRS 332.25 TRY 244.26 TRY −26% vs LMAX
Reliance Industries Limited RELIANCE ₹1,324 ₹865.31 −35% vs LMAX
HF Sinclair Corporation DINO $99.76 $52.92 −47% vs LMAX
Neste Oyj NESTE €27.67 €11.70 −58% vs LMAX
Formosa Petrochemical Corporation 6505 88.40 TWD 35.53 TWD −60% vs LMAX
Valero Energy Corporation VLO $356.75 $131.30 −63% vs LMAX
Phillips 66 PSX $253.02 $86.38 −66% vs LMAX
Marathon Petroleum Corporation MPC $389.88 $113.66 −71% vs LMAX

Explore undervalued stocks

More undervalued Energy stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

PT Lupromax Pelumas Indonesia Tb: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "PT Lupromax Pelumas Indonesia Tb Fair Value". https://www.fairvalue-calculator.com/stock/LMAX

Frequently asked questions

Is PT Lupromax Pelumas Indonesia Tb (LMAX) overvalued or undervalued?
As of Nov 10, 2026, our model estimates a fair value of 74.62 IDR versus a price of 75.00 IDR, about 1% lower (fairly valued).
What is the fair value of LMAX?
Our model-based fair value for PT Lupromax Pelumas Indonesia Tb is 74.62 IDR (as of Nov 10, 2026), built from audited fundamentals. The current price: 75.00 IDR.
What is the quality score of LMAX?
PT Lupromax Pelumas Indonesia Tb has a Quality Score of 67/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for PT Lupromax Pelumas Indonesia Tb (LMAX)?
Our model-based price target is the fair value of 74.62 IDR (as of Nov 10, 2026) from 20 valuation models. Cautious scenario 63.96 IDR, optimistic scenario 93.22 IDR. It is a calculation from audited fundamentals, not an analyst target.
What is the PT Lupromax Pelumas Indonesia Tb stock forecast for 2026?
Our models put fair value at 74.62 IDR, about 1% lower versus a price of 75.00 IDR (fairly valued). Cautious scenario 63.96 IDR, optimistic scenario 93.22 IDR. The calculation is refreshed regularly with new filings.
What is the revenue of PT Lupromax Pelumas Indonesia Tb (LMAX)?
PT Lupromax Pelumas Indonesia Tb reported trailing-twelve-month revenue of about 67.7B IDR (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of PT Lupromax Pelumas Indonesia Tb (LMAX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For PT Lupromax Pelumas Indonesia Tb it is 74.62 IDR per share (as of Nov 10, 2026), against a price of 75.00 IDR. It is the blended result of 20 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is PT Lupromax Pelumas Indonesia Tb stock overvalued or undervalued in 2026?
As of Nov 10, 2026, LMAX trades above its calculated fair value: price 75.00 IDR, fair value 74.62 IDR, a gap of about −1% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of LMAX?
No. The price is what the market pays today (75.00 IDR); the fair value is what the company's own numbers justify (74.62 IDR). For PT Lupromax Pelumas Indonesia Tb the two are 0.3800 IDR per share apart. That gap is exactly why we show both numbers side by side.
How much is PT Lupromax Pelumas Indonesia Tb worth?
The market values PT Lupromax Pelumas Indonesia Tb at about 54.6B IDR (market capitalisation, as of Nov 10, 2026). Per share that is 75.00 IDR; our models calculate a fair value of 74.62 IDR per share.
What do the bullish and bearish scenarios say about LMAX?
Our models span a range for PT Lupromax Pelumas Indonesia Tb: cautious scenario 63.96 IDR, base 74.62 IDR, optimistic 93.22 IDR per share (as of Nov 10, 2026, price 75.00 IDR). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of PT Lupromax Pelumas Indonesia Tb (LMAX)?
Balance-sheet figures for PT Lupromax Pelumas Indonesia Tb (as of Nov 10, 2026): return on equity 1.4%, debt of 0.03 per unit of equity. They feed the Quality Score of 67/100, which measures business quality independently of the share price.
How far is LMAX from its 52-week high?
PT Lupromax Pelumas Indonesia Tb trades at 75.00 IDR, about 67% below its 52-week high of 226.00 IDR and 32% above the low of 57.00 IDR (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of 74.62 IDR is for.
Which stocks are comparable to PT Lupromax Pelumas Indonesia Tb?
From the same area (Energy) we also value Reliance Industries Limited, Valero Energy Corporation, Phillips 66, Marathon Petroleum Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is PT Lupromax Pelumas Indonesia Tb stock attractive at the current price?
The data as of Nov 10, 2026: price 75.00 IDR, calculated fair value 74.62 IDR (−1%), Quality Score 67/100, from 20 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of LMAX calculated?
We run PT Lupromax Pelumas Indonesia Tb through 20 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 74.62 IDR builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.7% above its aggregate fair value. PT Lupromax Pelumas Indonesia Tb itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of PT Lupromax Pelumas Indonesia Tb (LMAX)?
The closing price on Nov 10, 2026 was 75.00 IDR. Our model-based fair value is 74.62 IDR, about 1% lower (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with PT Lupromax Pelumas Indonesia Tb right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of PT Lupromax Pelumas Indonesia Tb

How large is the market capitalisation of PT Lupromax Pelumas Indonesia Tb (LMAX)?
The market capitalisation of PT Lupromax Pelumas Indonesia Tb is 54.6B IDR (≈ $3.0M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of PT Lupromax Pelumas Indonesia Tb (LMAX)?
The price-to-sales ratio of PT Lupromax Pelumas Indonesia Tb is 0.81 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of PT Lupromax Pelumas Indonesia Tb (LMAX)?
The net margin of PT Lupromax Pelumas Indonesia Tb is 1.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of PT Lupromax Pelumas Indonesia Tb (LMAX)?
The return on equity (ROE) of PT Lupromax Pelumas Indonesia Tb is 1.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of PT Lupromax Pelumas Indonesia Tb (LMAX)?
On an EBIT basis the return on assets of PT Lupromax Pelumas Indonesia Tb is 6.9% (avg 3y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of PT Lupromax Pelumas Indonesia Tb (LMAX)?
The operating margin of PT Lupromax Pelumas Indonesia Tb is 3.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at PT Lupromax Pelumas Indonesia Tb (LMAX)?
Revenue at PT Lupromax Pelumas Indonesia Tb is growing −12.1% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at PT Lupromax Pelumas Indonesia Tb (LMAX)?
Earnings per share at PT Lupromax Pelumas Indonesia Tb are growing −46.3% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed

Watch PT Lupromax Pelumas Indonesia Tb in the live analysis

One click puts PT Lupromax Pelumas Indonesia Tb on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.